A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators ...
Mar 8, 2023
0
111
On the road, putting a foot on the gas or brake pedal controls the car's speed. This also happens in our body, in driving an immune response. Like human drivers, antibodies have a "foot"—a sort of molecular limb that "presses" ...
Mar 6, 2023
0
34
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2.
Feb 15, 2023
1
137
A new analysis by Cedars-Sinai investigators is furthering the scientific community's understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in ...
Jan 10, 2023
0
39
A team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of SARS-CoV-specific antibodies after multiple vaccinations with the Comirnaty mRNA vaccine. They have now published ...
Jan 9, 2023
0
47
Myocarditis, a condition in which the heart muscle becomes inflamed, is a rare complication that can occur after mRNA COVID vaccination. It's estimated that roughly 18 cases occur in every 1 million vaccine doses administered, ...
Jan 4, 2023
0
34
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to ...
Dec 15, 2022
0
9
Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify ...
Dec 14, 2022
0
37
Nearly three years into the pandemic, many of us now carry antibodies against the virus—due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses ...
Dec 6, 2022
0
27
Three currently circulating omicron subvariants of SARS-CoV-2—including two that currently make up almost 50% of reported COVID-19 infections in the U.S.—are better at evading vaccine- and infection-generated neutralizing ...
Nov 22, 2022
1
95
